×
Biolase EBITDA 2010-2024 | BIOL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Biolase ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Biolase EBITDA 2010-2024 | BIOL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Biolase ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Becton Dickinson (BDX)
$67.7B
McKesson (MCK)
$67.3B
Cardinal Health (CAH)
$27.6B
Cooper (COO)
$22B
West Pharmaceutical Services (WST)
$21.8B
Labcorp (LH)
$18.6B
Align Technology (ALGN)
$18.2B
Henry Schein (HSIC)
$8.9B
Merit Medical Systems (MMSI)
$5.6B
DENTSPLY SIRONA (XRAY)
$5.3B
CONMED (CNMD)
$2.3B
Patterson (PDCO)
$1.9B
STAAR Surgical (STAA)
$1.6B
Lifevantage (LFVN)
$131M
Pro-Dex (PDEX)
$90M